{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T01:49:56Z","timestamp":1663811396873},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00393-020-00827-x","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T17:24:03Z","timestamp":1593192243000},"page":"571-573","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ein langj\u00e4hriges Sj\u00f6gren-Syndrom ohne erh\u00f6htes Lymphomrisiko"],"prefix":"10.1007","volume":"79","author":[{"given":"T.","family":"Witte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,26]]},"reference":[{"key":"827_CR1","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/acr.22968","volume":"69","author":"SE Carsons","year":"2017","unstructured":"Carsons\u00a0SE, Vivino\u00a0FB, Parke\u00a0A et\u00a0al (2017) Treatment guidelines for rheumatologic manifestations of Sj\u00f6gren\u2019s syndrome: use of biologic agents, management of fatigue, and inflammatory musculoskeletal pain. Arthritis Care Res 69:517\u2013527","journal-title":"Arthritis Care. Res."},{"key":"827_CR2","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1111\/j.1532-5415.2008.01737.x","volume":"56","author":"ML Chew","year":"2008","unstructured":"Chew\u00a0ML, Mulsant\u00a0BH, Pollock\u00a0BG et\u00a0al (2008) Anticholinergic activity of 107 medications commonly used by older adults. J\u00a0Am Geriatr Soc 56:1333\u20131341","journal-title":"J Am Geriatr Soc"},{"issue":"Suppl 1","key":"827_CR3","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1177\/0961203396005001081","volume":"5","author":"RI Fox","year":"1996","unstructured":"Fox\u00a0RI, Dixon\u00a0R, Guarrasi\u00a0V, Krubel\u00a0S (1996) Treatment of primary Sj\u00f6gren\u2019s syndrome with\u00a0hydroxychloroquine: a\u00a0retrospective, open-label study. Lupus 5(Suppl 1):S31\u2013S36","journal-title":"Lupus"},{"key":"827_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jama.2014.7682","volume":"312","author":"JE Gottenberg","year":"2014","unstructured":"Gottenberg\u00a0JE, Ravaud\u00a0P, Pu\u00e9chal\u00a0X et\u00a0al (2014) Effects of hydroxychloroquine on symptomatic improvement in primary Sj\u00f6gren syndrome: the JOQUER randomized clinical trial. JAMA 312:249\u2013258","journal-title":"JAMA"},{"key":"827_CR5","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/art.1780281008","volume":"28","author":"PF Kohler","year":"1985","unstructured":"Kohler\u00a0PF, Winter\u00a0ME (1985) A quantitative test for xerostomia. The Saxon test, an oral equivalent of the Schirmer test. Arthritis Rheum 28:1128\u20131132","journal-title":"Arthritis Rheum"},{"key":"827_CR6","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/art.27314","volume":"62","author":"JM Meijer","year":"2010","unstructured":"Meijer\u00a0JM, Meiners\u00a0PM, Vissink\u00a0A et al (2010) Effectiveness of rituximab treatment in primary Sj\u00f6gren\u2019s syndrome: a\u00a0randomized, double-blind, placebo-controlled trial. Arthritis Rheum 62:960\u2013968","journal-title":"Arthritis Rheum"},{"key":"827_CR7","first-page":"59","volume":"78","author":"M Ramos-Casals","year":"2019","unstructured":"Ramos-Casals\u00a0M, Brito-Zer\u00f3n\u00a0P, Bombardieri\u00a0S et al (2019) SP0190. 2019 Eular recommendations for the management of Sj\u00f6gren\u2019s syndrome with topical and systemic therapies. Ann Rheum Dis 78:59","journal-title":"Ann Rheum Dis"},{"key":"827_CR8","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","volume":"107","author":"K Sall","year":"2000","unstructured":"Sall\u00a0K, Stevenson\u00a0OD, Mundorf\u00a0TK, Reis\u00a0BL (2000) Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology 107:631\u2013639","journal-title":"Ophthalmology"},{"key":"827_CR9","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1001\/archinte.159.2.174","volume":"159","author":"FB Vivino","year":"1999","unstructured":"Vivino\u00a0FB, Al-Hashimi\u00a0I, Khan\u00a0Z et al (1999) Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sj\u00f6gren syndrome: a\u00a0randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group. Arch Intern Med 159:174\u2013181","journal-title":"Arch Intern Med"},{"key":"827_CR10","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.rdc.2016.03.010","volume":"42","author":"FB Vivino","year":"2016","unstructured":"Vivino\u00a0FB, Carsons\u00a0SE, Foulks\u00a0G et\u00a0al (2016) New Treatment Guidelines for Sj\u00f6gren\u2019s Disease. Rheum Dis Clin N Am 42:531\u2013551","journal-title":"Rheum Dis Clin N Am"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-020-00827-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-020-00827-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-020-00827-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T23:32:16Z","timestamp":1624663936000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-020-00827-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,26]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["827"],"URL":"https:\/\/doi.org\/10.1007\/s00393-020-00827-x","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,26]]},"assertion":[{"value":"26 June 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"T.\u00a0Witte gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden vom Autor keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}